> ## Content Index
> Fetch the complete content index at: https://www.huntingalphas.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pfizer: Too Early For A Turnaround (Archive)
- URL: https://www.huntingalphas.com/pfizer-too-early-for-a-turnaround-archive/
- Published: 2024-06-06T13:30:00.000Z
- Updated: 2026-02-27T09:49:04.000Z
- Description: Pfizer’s oncology pivot and CEO incentives cloud the timing and quality of any turnaround.
- Author: Vish (Hunting Alphas)
- Tags: 5-Minute Pitches, #noindex, Archive, #sa-origin, PFE, Healthcare

*This 5-Minute Pitch was originally published on Seeking Alpha before the launch of the Hunting Alphas website. It is shared here to showcase my previous work and track record. New 5-Minute Pitches published on this site will not be disseminated anywhere else.*

## Elevator Pitch

- I had a 'Hold/Neutral' stance on Pfizer in my last update, but the stock has performed worse than my expectations; lagging the S&P 500 by 8.46%. Yet, I maintain my stance.
- I've been skeptical of Pfizer's expensive acquisition of Seagen. I believe the short-term performance incentives of the CEO are not well-aligned to value creation.
- Pfizer's business has seen stagnant sales over the last few years besides the one-off of COVID vaccines. The oncology drugs pipeline shows us that the key catalysts are in 2025-2026.
- Hence, I believe it is too early for a turnaround case to be made, especially since there is no compelling valuation discount for buyers.

Read the full article [here](https://seekingalpha.com/article/4697702-pfizer-stock-too-early-for-a-turnaround-maintain-hold?ref=huntingalphas.com).

#### Disclosures and Disclaimers

**Past performance ≠ future results. Not investment advice. See* [**full Disclaimer*](https://www.huntingalphas.com/disclaimer/)**.*